The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (136.11) USD. With the latest stock price at 9.03 USD, the upside of Regenxbio Inc based on DCF is -1607.3%.
Based on the latest price of 9.03 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 1607.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.4% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (464.45) - (81.77) | (136.11) |
| Upside | -5243.4% - -1005.6% | -1607.3% |